AMG National Trust Bank Has $6.38 Million Stake in Xylem Inc. $XYL

Key Points

• AMG National Trust Bank increased its position in Xylem by 315.5% in Q4, owning 46,874 shares valued at about $6.38 million.
• Xylem’s board approved a $1.50 billion share repurchase program (up to 4.8% of shares) and raised its quarterly dividend to $0.43 (annualized $1.72, ~1.4% yield).
• The company reported Q EPS of $1.42, in line with estimates, set FY 2026 guidance at 5.350–5.560 EPS (consensus ~5.46), and carries a consensus "Moderate Buy" rating with a $153.77 target.

AMG National Trust Bank increased its position in Xylem Inc. (NYSE:XYL - Free Report) by 315.5% during the fourth quarter, according to its most recent Form 13F filing with the SEC. The fund owned 46,874 shares of the industrial products company's stock after buying an additional 35,592 shares during the period. AMG National Trust Bank's holdings in Xylem were worth $6,383,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors have also recently added to or reduced their stakes in the company. SJS Investment Consulting Inc. lifted its position in shares of Xylem by 1,844.4% in the third quarter. SJS Investment Consulting Inc. now owns 175 shares of the industrial products company's stock worth $26,000 after buying an additional 166 shares during the last quarter. Knuff & Co LLC acquired a new position in shares of Xylem during the 3rd quarter valued at about $27,000. Board of the Pension Protection Fund bought a new position in shares of Xylem in the 4th quarter valued at approximately $27,000. Wexford Capital LP bought a new position in shares of Xylem in the 3rd quarter valued at approximately $27,000. Finally, First Horizon Corp acquired a new stake in Xylem in the 3rd quarter worth approximately $30,000. Institutional investors own 87.96% of the company's stock.

Xylem Trading Up 1.6%

Shares of XYL stock opened at $123.46 on Tuesday. The firm has a market capitalization of $30.02 billion, a P/E ratio of 31.49, a price-to-earnings-growth ratio of 1.74 and a beta of 1.18. Xylem Inc. has a 1 year low of $114.49 and a 1 year high of $154.27. The firm's fifty day simple moving average is $123.99 and its 200 day simple moving average is $135.30. The company has a current ratio of 1.62, a quick ratio of 1.28 and a debt-to-equity ratio of 0.12.

Xylem (NYSE:XYL - Get Free Report) last issued its quarterly earnings results on Tuesday, February 10th. The industrial products company reported $1.42 earnings per share for the quarter, meeting analysts' consensus estimates of $1.42. Xylem had a net margin of 10.59% and a return on equity of 11.11%. During the same period in the prior year, the firm posted $1.18 earnings per share. The company's revenue was up 6.3% compared to the same quarter last year. Xylem has set its FY 2026 guidance at 5.350-5.560 EPS. As a group, sell-side analysts predict that Xylem Inc. will post 5.46 EPS for the current year.

Xylem declared that its board has approved a stock repurchase plan on Wednesday, February 25th that permits the company to repurchase $1.50 billion in shares. This repurchase authorization permits the industrial products company to buy up to 4.8% of its shares through open market purchases. Shares repurchase plans are often an indication that the company's leadership believes its stock is undervalued.

Xylem Increases Dividend

The company also recently announced a quarterly dividend, which was paid on Tuesday, March 24th. Investors of record on Tuesday, February 24th were given a dividend of $0.43 per share. This represents a $1.72 dividend on an annualized basis and a yield of 1.4%. This is a boost from Xylem's previous quarterly dividend of $0.40. The ex-dividend date of this dividend was Tuesday, February 24th. Xylem's dividend payout ratio (DPR) is 43.88%.

Analysts Set New Price Targets

XYL has been the subject of a number of recent analyst reports. Weiss Ratings cut Xylem from a "buy (b-)" rating to a "hold (c+)" rating in a research report on Monday, April 6th. Oppenheimer restated an "outperform" rating and issued a $160.00 price objective (down from $165.00) on shares of Xylem in a research note on Wednesday, April 1st. Royal Bank Of Canada decreased their price objective on shares of Xylem from $176.00 to $162.00 and set an "outperform" rating for the company in a report on Wednesday, February 11th. William Blair started coverage on shares of Xylem in a research note on Monday, January 26th. They issued an "outperform" rating on the stock. Finally, The Goldman Sachs Group set a $158.00 target price on shares of Xylem in a research report on Wednesday, February 11th. Eight investment analysts have rated the stock with a Buy rating and seven have assigned a Hold rating to the stock. According to data from MarketBeat, the company presently has an average rating of "Moderate Buy" and a consensus price target of $153.77.

Xylem Company Profile

Xylem Inc NYSE: XYL is a global water technology company that designs, manufactures and services engineered systems and equipment for the transport, treatment, testing and efficient use of water. Its product portfolio spans pumps and pumping systems, valves, filtration and disinfection equipment, sensors and analytical instruments, and digital solutions for monitoring and control of water infrastructure. Xylem serves the full water cycle with offerings for water and wastewater utilities, industrial customers, commercial and residential buildings, and agricultural applications.

The company was established as an independent publicly traded company in 2011 following a corporate spin-off from ITT Corporation and is headquartered in Rye Brook, New York.

Want to see what other hedge funds are holding XYL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Xylem Inc. (NYSE:XYL - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.